Dual-time-point FDG PET/CT imaging in prosthetic heart valve endocarditis

Journal of Nuclear Cardiology

Volumn 25, Issue 6, 2018, Pages 1960-1967

  Scholtens, A M ^a   Swart, L E ^b   Verberne, H J ^c   Budde, R P J ^b   Lam, M G E H ^d  

^a MEANDER MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

endocarditis; FDG PET CT; prosthetic heart valve

Indexed keywords

ANTIBIOTIC AGENT; FLUORODEOXYGLUCOSE; GLUCOSE; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ANTIBIOTIC THERAPY; AORTIC VALVE REPLACEMENT; ARTICLE; CLINICAL ARTICLE; FALSE POSITIVE RESULT; FOLLOW UP; GLUCOSE METABOLISM; HEART VALVE REPLACEMENT; HUMAN; MAXIMUM STANDARDIZED UPTAKE VALUE; MIDDLE AGED; MITRAL VALVE REPLACEMENT; POSITRON EMISSION TOMOGRAPHY-COMPUTED TOMOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSTHETIC HEART VALVE ENDOCARDITIS; PROSTHETIC VALVE ENDOCARDITIS; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; VERY ELDERLY; ADVERSE EVENT; BACTERIAL ENDOCARDITIS; DIAGNOSTIC IMAGING; INFECTION; PROCEDURES;

ADULT; AGED; AGED, 80 AND OVER; ENDOCARDITIS, BACTERIAL; FLUORODEOXYGLUCOSE F18; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MIDDLE AGED; POSITRON EMISSION TOMOGRAPHY COMPUTED TOMOGRAPHY; PROSTHESIS-RELATED INFECTIONS; RADIOPHARMACEUTICALS;

EID: 85018732275     PISSN: 10713581     EISSN: 15326551     Source Type: Journal    
DOI: 10.1007/s12350-017-0902-3     Document Type: Article

References (18)

1. Yacoub MH, Takkenberg JJ. Will heart valve tissue engineering change the world? Nat Clin Pract Cardiovasc Med. 2005;2:60–1
2. Thuny F, Grisoli D, Collart F, Habib G, Raoult D. Management of infective endocarditis: Challenges and perspectives. Lancet. 2012;379:965–75
3. Choussat R, Thomas D, Isnard R, Michel PL, Iung B, Hanania G, et al. Perivalvular abscesses associated with endocarditis; clinical features and prognostic factors of overall survival in a series of 233 cases. Perivalvular abscesses french multicentre study. Eur Heart J. 1999;20:232–41
4. Vieira ML, Grinberg M, Pomerantzeff PM, Andrade JL, Mansur AJ. Repeated echocardiographic examinations of patients with suspected infective endocarditis. Heart. 2004;90:1020–4
5. Hill EE, Herijgers P, Claus P, Vanderschueren S, Peetermans WE, Herregods MC. Abscess in infective endocarditis: The value of transesophageal echocardiography and outcome: A 5-year study. Am Heart J. 2007;154:923–8
6. Habets J, Tanis W, van Herwerden LA, van den Brink RB, Mali WP, de Mol BA, et al. Cardiac computed tomography angiography results in diagnostic and therapeutic change in prosthetic heart valve endocarditis. Int J Cardiovasc Imaging. 2014;30:377–87
7. Saby L, Laas O, Habib G, Cammilleri S, Mancini J, Tessonnier L, et al. Positron emission tomography/computed tomography for diagnosis of prosthetic valve endocarditis: Increased valvular 18F-fluorodeoxyglucose uptake as a novel major criterion. J Am Coll Cardiol. 2013;61:2374–82
8. Tanis W, Scholtens A, Habets J, van den Brink RB, van Herwerden LA, Chamuleau SA, et al. CT angiography and (18)F-FDG-PET fusion imaging for prosthetic heart valve endocarditis. JACC Cardiovasc Imaging. 2013;6:1008–13
9. Ricciardi A, Sordillo P, Ceccarelli L, Maffongelli G, Calisti G, Di Pietro B, et al. 18-fluoro-2-deoxyglucose positron emission tomography-computed tomography: An additional tool in the diagnosis of prosthetic valve endocarditis. Int J Infect Dis. 2014;28:219–24
10. Rouzet F, Chequer R, Benali K, Lepage L, Ghodbane W, Duval X, et al. Respective performance of 18F-FDG PET and radiolabeled leukocyte scintigraphy for the diagnosis of prosthetic valve endocarditis. J Nucl Med. 2014;55:1980–5
11. Authors/Task Force Members, Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, et al. ESC guidelines for the management of infective endocarditis: The task force for the management of infective endocarditis of the european society of cardiology (ESC)endorsed by: European association for cardio-thoracic surgery (EACTS), the european association of nuclear medicine (EANM). Eur Heart J 2015;17:277
12. Van Riet J, Hill EE, Gheysens O, Dymarkowski S, Herregods MC, Herijgers P, et al. (18)F-FDG PET/CT for early detection of embolism and metastatic infection in patients with infective endocarditis. Eur J Nucl Med Mol Imaging. 2010;37:1189–97
13. Caldarella C, Leccisotti L, Treglia G, Giordano A. Which is the optimal acquisition time for FDG PET/CT imaging in patients with infective endocarditis? J Nucl Cardiol. 2013;20:307–9
14. Leccisotti L, Perna F, Lago M, Leo M, Stefanelli A, Calcagni ML, et al. Cardiovascular implantable electronic device infection: Delayed vs standard FDG PET-CT imaging. J Nucl Cardiol. 2014;21:622–32
15. McCulloch P, Altman DG, Campbell WB, Flum DR, Glasziou P, Marshall JC, et al. No surgical innovation without evaluation: The IDEAL recommendations. Lancet. 2009;374:1105–12
16. Scholtens AM, Verberne HJ, Budde RP, Lam M. Additional heparin pre-administration improves cardiac glucose metabolism suppression over low carbohydrate diet alone in 18F-FDG-PET imaging. J Nucl Med. 2015;36:3075–128
17. Scholtens AM, Swart LE, Verberne HJ, Tanis W, Lam MG, Budde RP. Confounders in FDG-PET/CT imaging of suspected prosthetic valve endocarditis. JACC Cardiovasc Imaging. 2016;9(12):1462–5
18. Scholtens AM, van Aarnhem EE, Budde RP. Effect of antibiotics on FDG-PET/CT imaging of prosthetic heart valve endocarditis. Eur Heart J Cardiovasc Imaging. 2015;16(11):1223